# Commission Implementing Decision (EU) 2017/2201 of 27 November 2017 authorising the placing on the market of 2′-fucosyllactose produced with Escherichia coli strain BL21 as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 7662) (Only the German text is authentic), Annex II: Authorised uses of 2′-fucosyllactose powder and liquid concentrate

Extent: E+W+S+N.I.

Food category
Maximum level
Infant formulae and follow-on formulae
1,2 gram 2′-fucosyllactose per litre final product ready for use marketed as such or reconstituted as instructed by the manufacturer.

---
Source: https://www.legislation.gov.uk/eudn/2017/2201/annex/II (the official version)
Page: https://openlegislation.uk/eu-decision-2017-2201/annex-II
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.